Publication:
Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting

Placeholder

Organizational Units

Program

Authors

DİNLEYİCİ, ENER ÇAĞRI
Dalgic, Nazan
Guven, Sirin
Metin, Ozge
Yasa, Olcay
Kurugol, Zafer
TÜREL, Özden
Tanir, Gonul
Yazar, Ahmet Sami
Arica, Vefik

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Objective: Two randomized controlled clinical trials have shown that Lactobacillus (L) reuteri DSM 17938 reduces the duration of diarrhea in children hospitalized due to acute infectious diarrhea. This was the first trial evaluating the efficacy of L. reuteri DSM 17938 in outpatient children with acute infectious diarrhea.

Description

Source:

Keywords:

Keywords

Citation

DİNLEYİCİ E. Ç. , Dalgic N., Guven S., Metin O., Yasa O., Kurugol Z., TÜREL Ö., Tanir G., Yazar A. S. , Arica V., et al., -Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting-, JORNAL DE PEDIATRIA, cilt.91, ss.392-396, 2015

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal